DK0823428T3 - Neuraminsyrederivater, deres fremstilling og deres medicinske anvendelse - Google Patents

Neuraminsyrederivater, deres fremstilling og deres medicinske anvendelse

Info

Publication number
DK0823428T3
DK0823428T3 DK97305159T DK97305159T DK0823428T3 DK 0823428 T3 DK0823428 T3 DK 0823428T3 DK 97305159 T DK97305159 T DK 97305159T DK 97305159 T DK97305159 T DK 97305159T DK 0823428 T3 DK0823428 T3 DK 0823428T3
Authority
DK
Denmark
Prior art keywords
preparation
acid derivatives
medical use
formula
neuraminic acid
Prior art date
Application number
DK97305159T
Other languages
Danish (da)
English (en)
Inventor
Takeshi Honda
Yoshiyuki Kobayashi
Takeshi Masuda
Makoto Yamashita
Masami Arai
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of DK0823428T3 publication Critical patent/DK0823428T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK97305159T 1996-07-22 1997-07-11 Neuraminsyrederivater, deres fremstilling og deres medicinske anvendelse DK0823428T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19186296 1996-07-22
JP8688897 1997-04-04

Publications (1)

Publication Number Publication Date
DK0823428T3 true DK0823428T3 (da) 2002-02-18

Family

ID=26427962

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97305159T DK0823428T3 (da) 1996-07-22 1997-07-11 Neuraminsyrederivater, deres fremstilling og deres medicinske anvendelse

Country Status (20)

Country Link
EP (1) EP0823428B1 (cs)
KR (1) KR100506578B1 (cs)
CN (1) CN1127494C (cs)
AT (1) ATE211468T1 (cs)
AU (1) AU700926B2 (cs)
CA (1) CA2210492C (cs)
CZ (1) CZ291960B6 (cs)
DE (1) DE69709795T2 (cs)
DK (1) DK0823428T3 (cs)
ES (1) ES2167682T3 (cs)
HK (1) HK1007879A1 (cs)
HU (1) HU223494B1 (cs)
ID (1) ID17474A (cs)
IL (1) IL121305A (cs)
MX (1) MX9705559A (cs)
NO (1) NO317704B1 (cs)
NZ (1) NZ328353A (cs)
PT (1) PT823428E (cs)
RU (1) RU2124509C1 (cs)
TW (1) TW418200B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US6451766B1 (en) 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
TWI291462B (en) 2000-04-25 2007-12-21 Daiichi Sankyo Co Ltd Hydrate crystal of neuraminic acid compound
FR2809104B1 (fr) * 2000-05-19 2002-08-02 Univ Paris Curie Procede de traitement de matiere vegetale, compositions comportant des derives du type n-acylglucosamine, utilisation de ces composes en tant qu'agents bio- protecteurs, et matiere vegetale traitee.
AU2001256759A1 (en) * 2000-05-19 2001-11-26 Sankyo Company Limited Sialic acid derivatives
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
WO2002076980A1 (fr) * 2001-03-27 2002-10-03 Sankyo Company, Limited Derives d'acide sialique
WO2002092555A1 (fr) * 2001-05-11 2002-11-21 Sankyo Company, Limited Derives d'acides sialiques
ATE526960T1 (de) * 2007-03-07 2011-10-15 Daiichi Sankyo Co Ltd Arzneimittel zur behandlung von grippe
TWI417297B (zh) * 2007-04-11 2013-12-01 Daiichi Sankyo Co Ltd 神經胺酸衍生物及其製造方法
KR100930963B1 (ko) * 2008-02-26 2009-12-11 한국기계연구원 적층형 압전파이로트 밸브를 이용한 공조기용 팽창밸브
CA2744793A1 (en) * 2008-11-28 2010-06-03 Cipla Limited Process for preparing zanamivir and intermediates for use in the process
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
NZ596492A (en) 2009-05-15 2013-08-30 Redx Pharma Ltd Redox drug derivatives
CN102532080A (zh) * 2010-12-29 2012-07-04 中国科学院上海药物研究所 新型唾液酸衍生物及其制备方法,包含该衍生物的药物组合物,以及其用途
CA2859296C (en) * 2011-12-16 2016-10-11 Daiichi Sankyo Company, Limited Method for manufacturing neuraminic acid derivatives
CN111116567B (zh) * 2013-09-09 2023-10-10 中国科学院上海有机化学研究所 扎那米韦和拉那米韦的中间体及其合成方法
CN114843564B (zh) * 2022-03-28 2023-08-25 电子科技大学 一种阴阳离子共掺杂的固体氧化物电池氧电极材料及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.
AU659501B2 (en) * 1991-10-23 1995-05-18 Biota Scientific Management Pty Ltd Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9400206D0 (en) * 1994-01-07 1994-03-02 Glaxo Group Ltd Chemical compound
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds

Also Published As

Publication number Publication date
KR100506578B1 (ko) 2005-12-26
CA2210492C (en) 2002-10-29
EP0823428A3 (en) 1998-02-25
AU2866297A (en) 1998-07-02
EP0823428B1 (en) 2002-01-02
ES2167682T3 (es) 2002-05-16
EP0823428A2 (en) 1998-02-11
NO973363L (no) 1998-01-23
CZ291960B6 (cs) 2003-06-18
HU9701270D0 (en) 1997-09-29
IL121305A0 (en) 1998-01-04
NZ328353A (en) 1998-03-25
KR980009253A (ko) 1998-04-30
ATE211468T1 (de) 2002-01-15
HK1007879A1 (en) 1999-04-30
CN1172807A (zh) 1998-02-11
DE69709795T2 (de) 2002-09-26
RU2124509C1 (ru) 1999-01-10
CN1127494C (zh) 2003-11-12
TW418200B (en) 2001-01-11
MX9705559A (es) 1998-05-31
PT823428E (pt) 2002-04-29
ID17474A (id) 1998-01-08
DE69709795D1 (de) 2002-02-28
HU223494B1 (hu) 2004-08-30
HUP9701270A3 (en) 2002-08-28
NO317704B1 (no) 2004-12-06
HUP9701270A2 (hu) 1999-09-28
NO973363D0 (no) 1997-07-21
IL121305A (en) 2003-01-12
CZ231697A3 (cs) 1998-02-18
CA2210492A1 (en) 1998-01-22
AU700926B2 (en) 1999-01-14

Similar Documents

Publication Publication Date Title
DK0823428T3 (da) Neuraminsyrederivater, deres fremstilling og deres medicinske anvendelse
BR0211900A (pt) Método para inibição do desenvolvimento de vìrus e/ou virucida, análogos de nucleotìdeo de pirazina e de nucleosìdeo de pirazina, precursor do inibidor da polimerase de rna, inibidor da polimerase de rna, método para tratar pacientes infectados por vìrus, e, usos de um análogo de nucleotìdeo de pirazina ou um sal deste e de um análogo de nucleosìdeo de pirazina ou um sal deste
US6046228A (en) Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
HUP0202593A2 (hu) Reverz transzkriptáz inhibitor hatású benzofenonok és ilyen vegyületeket tartalmazó gyógyászati készítmények
NO302574B1 (no) Indolkarbazolimider og deres anvendelse
BR9812364A (pt) Composto, uso do mesmo, composição farmacêutica, derivado de amida, e, processo para a preparação de um derivado de amida ou de um sal farmaceuticamente aceitável ou éster clivável in vivo deste
BR0004786A (pt) Compostos farmaceuticamente ativos
KR920700217A (ko) 항 바이러스성 화합물
NL300202I1 (nl) Nucleotide-analogen.
NO305702B1 (no) 3'-substituert nukleosid-derivat eller et av dets farmas°ytisk akseptable salter, anvendelse derav og medisinsk preparat
DK132188D0 (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
DK527984D0 (da) 11-substituerede 5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepiner eller farmaceutisk acceptable salte deraf, deres fremstilling og mellemprodukter hertil samt deres anvendelse som antipsychotika og analgetika
DK0911026T3 (da) Creatinderivater for astma
DK0570245T3 (da) Octahydronaphthalenoximderivater til inbibering af kolesterolbiosyntese, deres fremstilling og anvendelse
ATE100439T1 (de) 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzol derivate.
KR101045985B1 (ko) 아릴 디케토산（ａｄｋ） 유도체를 유효성분으로 포함하는 사스 코로나 바이러스 저해용 조성물
TH83125B (th) อนุพันธ์เนยูรามินิคแอซิดการเตรียมของมันและการใช้ประโยชน์ของมันทางการแพทย์
SE8505534L (sv) Kemiska foreningar
ATE106727T1 (de) Verwendung eines benzo(b>thiophen-2- carboximidamid-derivates gegen herzinsuffizienz.
UA31078A (uk) Інгібітор вірусу імунодефіциту людини ( даримід )
RU2004104368A (ru) Применение соединений антивирусного класса для получения средства для лечения и профилактики вирусной инфекции дыхательного тракта
TH10355EX (th) นิวคลีโอไซด์ที่ใช้ในการรักษาโรค
BR9815690A (pt) Composto, processo para a preparação de qualquer um dos compostos, composição farmacêutica, e, uso do composto de 3-(nafter-1-il-óxi) - pirrolidina, 3-(5,6,7,8 - tetraidro-nafterc-1-il-óxi) - pirrolindina